论文部分内容阅读
目的探讨胺碘酮联合替米沙坦治疗急性心肌梗死(AMI)的临床疗效。方法选取2012年1月—2014年6月长春市中心医院收治的AMI患者66例,采用随机分组法将患者分为治疗组与对照组,各33例。对照组患者予以胺碘酮治疗,治疗组患者予以胺碘酮联合替米沙坦治疗。观察两组患者的临床疗效。结果治疗组有效率高于对照组,差异有统计学意义(P<0.05)。结论胺碘酮联合替米沙坦治疗AMI的临床疗效好,且无明显不良反应,有助于控制心房纤颤,提高院内急诊质量。
Objective To investigate the clinical efficacy of amiodarone combined with telmisartan in the treatment of acute myocardial infarction (AMI). Methods Sixty-six patients with AMI admitted to Changchun Central Hospital from January 2012 to June 2014 were randomly divided into treatment group and control group, with 33 cases in each group. Patients in the control group were treated with amiodarone, and patients in the treatment group were treated with amiodarone combined with telmisartan. To observe the clinical efficacy of two groups of patients. Results The treatment group was more effective than the control group, the difference was statistically significant (P <0.05). Conclusion Amiodarone combined with Telmisartan in the treatment of AMI has good clinical curative effect and no obvious side effects. It is helpful to control atrial fibrillation and improve the quality of emergency in hospital.